Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Repligen Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
RGEN
Nasdaq
2836
https://www.repligen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Repligen Corp
Repligen Appoints Maggie A. Pax to Board of Directors
- Mar 19th, 2024 11:30 am
Are Repligen Corporation's (NASDAQ:RGEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
- Mar 18th, 2024 2:30 pm
Repligen Corp CEO Anthony Hunt Sells 16,707 Shares
- Mar 12th, 2024 5:18 am
PBYI vs. RGEN: Which Stock Is the Better Value Option?
- Mar 4th, 2024 4:40 pm
Repligen Corp COO James Bylund Sells 4,373 Shares
- Feb 27th, 2024 7:02 am
Estimating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
- Feb 26th, 2024 11:25 am
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight
- Feb 24th, 2024 5:03 am
Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript
- Feb 22nd, 2024 4:24 pm
Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y
- Feb 22nd, 2024 3:39 pm
Repligen (RGEN) Lags Q4 Earnings and Revenue Estimates
- Feb 21st, 2024 1:45 pm
Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income
- Feb 21st, 2024 1:12 pm
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 21st, 2024 12:30 pm
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results
- Feb 7th, 2024 12:30 pm
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?
- Jan 31st, 2024 5:10 pm
Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?
- Jan 29th, 2024 10:09 am
HRMY vs. RGEN: Which Stock Is the Better Value Option?
- Jan 22nd, 2024 4:40 pm
Is Repligen Corporation (NASDAQ:RGEN) Potentially Undervalued?
- Jan 8th, 2024 2:08 pm
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Dec 19th, 2023 12:30 pm
Here’s Why Repligen Corporation (RGEN) Rose 13% in Q3
- Dec 18th, 2023 9:49 am
Repligen's (NASDAQ:RGEN) investors will be pleased with their impressive 158% return over the last five years
- Dec 7th, 2023 3:36 pm
Scroll